Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivonescimab + mFOLFOXIRI + Celecoxib in BRAF V600E-mutant Colorectal Cancer
NCT07809893Phase 2Recruiting
- Sponsor
- Sun Yat-sen University
- Start
- Aug 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
A Phase 2 trial of ivonescimab in colorectal cancer (CRC), sponsored by Sun Yat-sen University. Started Aug 2026; status: recruiting.
02
Drugs
ivonescimab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT07809893.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07809893.